Cystic Fibrosis News Community Forums Science and Research Inhalation Powder for CF Patients Introduced to Swiss Market

  • Inhalation Powder for CF Patients Introduced to Swiss Market

    Posted by Community Member on June 20, 2019 at 7:39 pm

    Under a license agreement with Pharmaxis, EffRx will move to bring Bronchitol (an inhaled dry powder formulation of mannitol) to CF patients in Switzerland. Click here to learn more.

    Is this drug available where you live?

    Community Member replied 6 years, 12 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.